The impact of viral evolution and frequency of variant epitopes on primary and memory human immunodeficiency virus type 1-specific CD8+ T cell responses

dc.contributor.authorMelhem, Nada Mohamad
dc.contributor.authorSmith, Kellie N.
dc.contributor.authorHuang, Xiaoli
dc.contributor.authorColleton, Bonnie A.
dc.contributor.authorJiang, Weimin
dc.contributor.authorMailliard, Robbie B.
dc.contributor.authorMullins, James I.
dc.contributor.authorRinaldo, Charles R.
dc.contributor.departmentMedical Laboratory Sciences Program (MLSP)
dc.contributor.facultyFaculty of Health Sciences (FHS)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:36:23Z
dc.date.available2025-01-24T11:36:23Z
dc.date.issued2014
dc.description.abstractIt is unclear if HIV-1 variants lose the ability to prime naïve CD8+ cytotoxic T lymphocytes (CTL) during progressive, untreated infection. We conducted a comprehensive longitudinal analysis of viral evolution and its impact on primary and memory CD8+ T cell responses pre-seroconversion (SC), post-SC, and during combination antiretroviral therapy (cART). Memory T cell responses targeting autologous virus variants reached a nadir by 8 years post-SC with development of AIDS, followed by a transient enhancement of anti-HIV-1 CTL responses upon initiation of cART. We show broad and high magnitude primary T cell responses to late variants in pre-SC T cells, comparable to primary anti-HIV-1 responses induced in T cells from uninfected persons. Despite evolutionary changes, CD8+ T cells could still be primed to HIV-1 variants. Hence, vaccination against late, mutated epitopes could be successful in enhancing primary reactivity of T cells for control of the residual reservoir of HIV-1 during cART. © 2013.
dc.identifier.doihttps://doi.org/10.1016/j.virol.2013.10.015
dc.identifier.eid2-s2.0-84890810921
dc.identifier.pmid24503065
dc.identifier.urihttp://hdl.handle.net/10938/28588
dc.language.isoen
dc.relation.ispartofVirology
dc.sourceScopus
dc.subjectAutologous viral variants
dc.subjectCart
dc.subjectHiv-1
dc.subjectMemory t cell responses
dc.subjectPrimary t cell responses
dc.subjectAdult
dc.subjectAnti-hiv agents
dc.subjectCd8-positive t-lymphocytes
dc.subjectCohort studies
dc.subjectEpitopes, t-lymphocyte
dc.subjectEvolution, molecular
dc.subjectHistocompatibility antigens class i
dc.subjectHiv infections
dc.subjectHumans
dc.subjectMale
dc.subjectT-lymphocytes
dc.subjectViral proteins
dc.subjectAbacavir
dc.subjectAntiretrovirus agent
dc.subjectCd8 antigen
dc.subjectEfavirenz
dc.subjectEfavirenz plus emtricitabine plus tenofovir disoproxil
dc.subjectEpitope
dc.subjectLamivudine
dc.subjectNelfinavir
dc.subjectSaquinavir
dc.subjectZidovudine
dc.subjectAcquired immune deficiency syndrome
dc.subjectAntigen specificity
dc.subjectArticle
dc.subjectCd8+ t lymphocyte
dc.subjectGenetic conservation
dc.subjectHuman
dc.subjectHuman cell
dc.subjectHuman immunodeficiency virus 1
dc.subjectHuman immunodeficiency virus 1 infection
dc.subjectImmunoreactivity
dc.subjectMemory t lymphocyte
dc.subjectNonhuman
dc.subjectPriority journal
dc.subjectSeroconversion
dc.titleThe impact of viral evolution and frequency of variant epitopes on primary and memory human immunodeficiency virus type 1-specific CD8+ T cell responses
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2014-10623.pdf
Size:
2.56 MB
Format:
Adobe Portable Document Format